Milestone Scientific (NYSE:MLSS) Shares Down 0.8% – What’s Next?

Milestone Scientific Inc. (NYSE:MLSS)’s stock price dropped 0.8% during mid-day trading on Thursday . The company traded as low as $0.26 and last traded at $0.2641. Approximately 52,957 shares changed hands during trading, a decline of 80% from the average daily volume of 270,350 shares. The stock had previously closed at $0.2662.

Analyst Ratings Changes

Separately, Benchmark lowered their target price on Milestone Scientific from $1.25 to $1.00 and set a “speculative buy” rating on the stock in a research note on Thursday, November 20th. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, Milestone Scientific has a consensus rating of “Buy” and an average target price of $1.00.

Milestone Scientific Trading Down 2.5%

The stock’s 50-day simple moving average is $0.29 and its 200-day simple moving average is $0.41. The stock has a market cap of $20.25 million, a price-to-earnings ratio of -3.68 and a beta of 0.97.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Milestone Scientific stock. Carnegie Investment Counsel acquired a new position in shares of Milestone Scientific Inc. (NYSE:MLSS) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 164,609 shares of the company’s stock, valued at approximately $105,000. Carnegie Investment Counsel owned approximately 0.21% of Milestone Scientific at the end of the most recent reporting period. 5.79% of the stock is currently owned by hedge funds and other institutional investors.

Milestone Scientific Company Profile

Milestone Scientific, Inc, listed on the New York Stock Exchange under the symbol MLSS, is a medical device company specializing in the development and commercialization of computer-controlled injection technologies for local anesthesia and pain management. The company’s proprietary systems are designed to enhance patient comfort, improve clinical outcomes and streamline the administration of anesthetics in dental and medical procedures. Through its precision delivery platforms, Milestone Scientific aims to set a new standard for minimally invasive injections.

At the core of Milestone Scientific’s product portfolio is the Single Tooth Anesthesia (STA) System, which uses Comunication Controlled Local Anesthetic Delivery (CCLAD) technology to provide targeted, atraumatic anesthesia for individual dental roots.